• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩斯卡索拉叶提取物对流感疫苗在小鼠模型中疗效的辅助潜力。

Adjuvant potential of Peyssonnelia caulifera extract on the efficacy of an influenza vaccine in a murine model.

机构信息

Interdisciplinary Graduate Program in Advanced Convergence Technology & Science, Jeju National University, Jeju, 63243, Republic of Korea.

Department of Veterinary Medicine, College of Veterinary Medicine, Jeju National University, Jeju, 63243, Republic of Korea.

出版信息

Sci Rep. 2024 Oct 25;14(1):25353. doi: 10.1038/s41598-024-76736-9.

DOI:10.1038/s41598-024-76736-9
PMID:39455811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512024/
Abstract

Natural adjuvants have recently garnered interest in the field of vaccinology as their immunostimulatory effects. In this study, we aimed to investigate the potential use of Peyssonnelia caulifera (PC), a marine alga, as a natural adjuvant for an inactivated split A/Puerto Rico/8/1934 H1N1 influenza vaccine (sPR8) in a murine model. We administered PC-adjuvanted vaccines to a murine model via intramuscular prime and boost vaccinations, and subsequently analyzed the induced immunological responses, particularly the production of antigen-specific IgG1 and IgG2a antibodies, memory T and B cell responses, and the protective efficacy against a lethal viral infection. PC extract significantly bolstered the vaccine efficacy, demonstrating balanced Th1/Th2 responses, increased memory T and B cell activities, and improved protection against viral infection. Notably, within 3 days post-vaccination, the PC adjuvant stimulated activation markers on dendritic cells (DCs) and macrophages at the inguinal lymph nodes (ILN), emphasizing its immunostimulatory capabilities. Furthermore, the safety profile of PC was confirmed, showing minimal local inflammation and no significant adverse effects post-vaccination. These findings contribute to our understanding of the immunomodulatory properties of natural adjuvants and suggest the promising roles of natural adjuvants in the development of more effective vaccines for infectious diseases.

摘要

天然佐剂因其免疫刺激作用,最近在疫苗学领域引起了关注。在这项研究中,我们旨在研究海洋藻类 Peyssonnelia caulifera(PC)作为灭活的 A/Puerto Rico/8/1934 H1N1 流感疫苗(sPR8)在小鼠模型中的天然佐剂的潜在用途。我们通过肌肉内初免和加强免疫接种将 PC 佐剂疫苗施用于小鼠模型,随后分析诱导的免疫反应,特别是抗原特异性 IgG1 和 IgG2a 抗体、记忆 T 和 B 细胞反应以及对致命病毒感染的保护效力。PC 提取物显著增强了疫苗的效力,表现出平衡的 Th1/Th2 反应、增加的记忆 T 和 B 细胞活性以及改善的对病毒感染的保护作用。值得注意的是,在接种疫苗后 3 天内,PC 佐剂刺激了腹股沟淋巴结(ILN)中的树突状细胞(DC)和巨噬细胞的激活标志物,强调了其免疫刺激能力。此外,PC 的安全性特征得到了证实,显示出最小的局部炎症,接种疫苗后没有明显的不良反应。这些发现有助于我们了解天然佐剂的免疫调节特性,并表明天然佐剂在开发更有效的传染病疫苗方面具有广阔的应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/e9175805ad14/41598_2024_76736_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/90391bde40dc/41598_2024_76736_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/fcf840035660/41598_2024_76736_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/a3980ef9fea5/41598_2024_76736_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/593cf0c12870/41598_2024_76736_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/062dbb80a096/41598_2024_76736_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/fb46c767f206/41598_2024_76736_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/cdf44be81a2e/41598_2024_76736_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/e9175805ad14/41598_2024_76736_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/90391bde40dc/41598_2024_76736_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/fcf840035660/41598_2024_76736_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/a3980ef9fea5/41598_2024_76736_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/593cf0c12870/41598_2024_76736_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/062dbb80a096/41598_2024_76736_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/fb46c767f206/41598_2024_76736_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/cdf44be81a2e/41598_2024_76736_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5359/11512024/e9175805ad14/41598_2024_76736_Fig8_HTML.jpg

相似文献

1
Adjuvant potential of Peyssonnelia caulifera extract on the efficacy of an influenza vaccine in a murine model.佩斯卡索拉叶提取物对流感疫苗在小鼠模型中疗效的辅助潜力。
Sci Rep. 2024 Oct 25;14(1):25353. doi: 10.1038/s41598-024-76736-9.
2
Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.不同佐剂在肌肉注射和鼻内给药途径下对去污剂裂解A/H3N2流感疫苗诱导的小鼠体液免疫和细胞免疫反应的影响。
Clin Vaccine Immunol. 2012 Feb;19(2):209-18. doi: 10.1128/CVI.05441-11. Epub 2011 Dec 21.
3
An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.基于甲病毒的佐剂增强了新生小鼠血清和粘膜抗体、T 细胞以及对流感病毒的保护免疫。
J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.
4
Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.NKT细胞激动剂α-半乳糖神经酰胺的辅助使用可增强基于M2的DNA疫苗的免疫原性及对甲型流感病毒的保护性免疫。
Arch Virol. 2017 May;162(5):1251-1260. doi: 10.1007/s00705-017-3230-7. Epub 2017 Jan 24.
5
A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity.一种新型合成双激动剂脂质体 TLR4/7 佐剂可增强流感疫苗的广泛免疫应答,且具有最小的致反应原性。
Front Immunol. 2020 Jun 19;11:1207. doi: 10.3389/fimmu.2020.01207. eCollection 2020.
6
Broadly Protective CD8 T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine.热休克蛋白 gp96 佐剂流感单价裂解疫苗诱导广泛保护性 CD8 T 细胞免疫应答针对高度保守表位。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00507-21.
7
DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.DAMP 诱导佐剂和 PAMP 佐剂并行增强流感裂解疫苗接种的保护性 2 型和 1 型免疫应答。
Front Immunol. 2018 Nov 20;9:2619. doi: 10.3389/fimmu.2018.02619. eCollection 2018.
8
Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.佐剂和免疫途径决定了全灭活流感病毒疫苗的交叉保护潜力和与保护相关的免疫机制。
Front Immunol. 2019 Mar 29;10:646. doi: 10.3389/fimmu.2019.00646. eCollection 2019.
9
Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant.没食子酸表没食子儿茶素酯作为一种新型疫苗佐剂。
Front Immunol. 2021 Nov 12;12:769088. doi: 10.3389/fimmu.2021.769088. eCollection 2021.
10
Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.新型 G3/DT 佐剂可增强季节性三价流感灭活裂解疫苗接种后的保护性 T 细胞应答。
Vaccine. 2014 Sep 29;32(43):5614-23. doi: 10.1016/j.vaccine.2014.08.003. Epub 2014 Aug 17.

本文引用的文献

1
Immunostimulatory effects of marine algae extracts on in vitro antigen-presenting cell activation and in vivo immune cell recruitment.海藻提取物对体外抗原呈递细胞激活及体内免疫细胞募集的免疫刺激作用
Food Sci Nutr. 2023 Aug 21;11(10):6560-6570. doi: 10.1002/fsn3.3605. eCollection 2023 Oct.
2
Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia.接种疫苗的小鼠中的流感突破性感染的特征是肺部无病理性嗜酸性粒细胞增多。
Front Immunol. 2023 Aug 4;14:1217181. doi: 10.3389/fimmu.2023.1217181. eCollection 2023.
3
Vaccine adjuvants: mechanisms and platforms.
疫苗佐剂:作用机制与平台。
Signal Transduct Target Ther. 2023 Jul 19;8(1):283. doi: 10.1038/s41392-023-01557-7.
4
Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice.慢性过敏性哮喘可诱导 T 细胞耗竭,并损害小鼠体内的病毒清除能力。
Respir Res. 2023 Jun 17;24(1):160. doi: 10.1186/s12931-023-02448-9.
5
Adjuvants approved for human use: What do we know and what do we need to know for designing good adjuvants?已批准用于人类的佐剂:为设计出优良佐剂,我们了解什么以及还需要了解什么?
Eur J Pharmacol. 2023 Apr 15;945:175632. doi: 10.1016/j.ejphar.2023.175632. Epub 2023 Mar 1.
6
Functional Hallmarks of Healthy Macrophage Responses: Their Regulatory Basis and Disease Relevance.健康巨噬细胞反应的功能特征:其调控基础和疾病相关性。
Annu Rev Immunol. 2022 Apr 26;40:295-321. doi: 10.1146/annurev-immunol-101320-031555.
7
Pattern recognition receptors in health and diseases.模式识别受体在健康与疾病中的作用
Signal Transduct Target Ther. 2021 Aug 4;6(1):291. doi: 10.1038/s41392-021-00687-0.
8
Dendritic cell migration in inflammation and immunity.树突状细胞在炎症和免疫中的迁移。
Cell Mol Immunol. 2021 Nov;18(11):2461-2471. doi: 10.1038/s41423-021-00726-4. Epub 2021 Jul 23.
9
Innate immune sensing of coronavirus and viral evasion strategies.先天免疫感知冠状病毒和病毒逃避策略。
Exp Mol Med. 2021 May;53(5):723-736. doi: 10.1038/s12276-021-00602-1. Epub 2021 May 6.
10
Emerging concepts in the science of vaccine adjuvants.疫苗佐剂科学中的新观点。
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.